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Abstract
Background: Chemotherapy-induced side effects may have a negative effect on nutrition intake, thus increasing
the risk of malnutrition and consequently, other serious complications for patients with cancer. The prevalence of
malnutrition is common among patients with colorectal cancer. Nurse-led empowering education may have a
positive effect on self-care activity in this patient group. Therefore, our purpose is to develop an empowering
educational nursing intervention and test its effect on self-care activation and knowledge level among patients with
colorectal cancer during chemotherapy. Secondary outcomes are quality of life and risk of malnutrition.
Methods: An interdisciplinary expert group developed a face-to-face empowering educational intervention using
teach-back method. A two-arm, single-centre, superiority trial with stratified randomisation (1:1) and pre-post
measures will be used to assess the effect of the intervention compared to standard care. Patients (N = 40 + 40) will
be recruited in one university hospital outpatient clinic in Finland. Eligibility criteria are adult patients diagnosed
with colorectal cancer starting oral fluoropyrimidine or combination chemotherapy treatment. A registered nurse
experienced in oncology will deliver the intervention 2 weeks after the first chemotherapy. Outcomes are measured
before intervention (M0) and after a two-month follow-up period (M1).
Discussion: This study will assess whether nurse-led empowering education using teach-back method is effective
on self-care activity among patients with colorectal cancer. If the intervention has a positive effect, it may be
implemented into patient education in a corresponding context.
Trial registration: ClinicalTrials.gov: NCT04160650 Registered 12 November 2019 - retrospectively registered
Keywords: Empowerment, Education, Self-care, Chemotherapy, Nutrition, Side effect, Patients with colorectal cancer
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: leetuo@utu.fi
1Comprehensive Cancer Center, Helsinki University Hospital, Haartmaninkatu
4, 0029 Helsinki, Finland
2Department of Nursing Science, University of Turku|, Joukahaisenkatu 3-5,
20014 Turku, Finland
Full list of author information is available at the end of the article
Tuominen et al. BMC Nursing           (2021) 20:94 
https://doi.org/10.1186/s12912-021-00617-z
Background
People are increasingly affected with colorectal cancer
(CRC), which is one of the most prevalent cancers glo-
bally, comprising about 10% of newly found cases [1, 2].
In Finland, about 3300 patients are diagnosed annually
with CRC, making it the second common cancer type
among both men and women [3]. Chemotherapy is a
common treatment for patients with operated high-risk
stage II and III CRC as well as advanced and metastatic
CRC [4]. Chemotherapy-related toxicities that affect the
ability to eat are known as nutrition impact side effects
(NIS). Side effects such as nausea, diarrhoea, constipa-
tion, mouth sores, heartburn, loss of appetite, altered
taste, cold sensitivity, pain, fatigue and distress may lead
to inadequate nutritional intake and weight loss, thus in-
creasing the risk of malnutrition [5–8].
Malnutrition is common among patients with CRC,
the prevalence varying according to patients’ age, cancer
type and stage of cancer [7, 8]. In malnutrition, a defi-
ciency or excess of energy, protein, and other nutrients
causes measurable adverse effects on body function and
clinical outcome [9]. The prevalence of both malnutri-
tion and NIS are higher in older population [10]. For ex-
ample, among geriatric patients with gastrointestinal
system cancer (n = 153) about 38% were malnourished
and 35% at risk of malnutrition at the time of the first
outpatient visit. Chemotherapy has been shown to in-
crease the incidence of malnutrition and weight loss [7,
11]. The complications of severe malnutrition may lead
to greater chemotherapy toxicity, worse physical func-
tion and quality of life (QoL), and reduced overall sur-
vival [12, 13]. Moreover, malnourished inpatients have
longer hospital length of stay and higher treatment costs
[8]. Therefore, it is essential to develop effective inter-
ventions to support empowerment and promote nutri-
tion intake of patients receiving chemotherapy.
Nutrition-related interventions for patients with can-
cer have been studied extensively with mixed results. In-
terventions have included individualised nutritional
support and counselling to reach protein and energy
goals [14], personalised nutrition intervention [15–17],
dietary counselling or advice [18, 19], oral nutritional
supplements (ONS), and nutrition advice with written
information [18]. Interventions have proved to be effect-
ive on energy and protein intake [14–19], weight [15],
QoL [14, 16, 17, 19], morbidity and mortality [14, 16,
17] as well as the risk of adverse clinical outcomes at 30
days [14]. Among patients with head and neck cancer
undergoing radiotherapy, individualised nutritional
counselling compared to ad libitum diet and ONS was
capable of sustaining a significant impact on patients’
outcomes after 3 months’ follow-up [16]. Conversely,
some of the interventions mentioned above have not
been effective on weight [18, 19], nutritional status, QoL,
functional status [18] and mortality. According to au-
thors, the lack of effect might have been related to small
sample sizes, short follow-up periods or low methodo-
logical quality of the studies [19]. Alternatively, Internet-
based interventions including information and some
interactive activities with experts to manage common
eating and nutritional problems during cancer treat-
ments have been tested. The results have not shown sta-
tistically significant changes on patients’ knowledge
levels, anxiety and QoL, probably due to limited sample
size or insufficient intervention [20].
Only few studies have explored the effect of nurse-led
nutritional interventions among this patient group, yet
the results have been promising. A multidisciplinary
team approach for nutritional interventions (individual
recipes, nutritional risk screening, total energy require-
ment calculation, education and diet adjustments) con-
ducted by specialist nurses has obtained a positive effect
on pre-albumin levels among CRC patients undergoing
chemotherapy [21]. An individualised educational pro-
gram with face-to-face and telephone counselling gained
positive results on energy and total protein intake
among patients with CRC (n = 19 + 21) in palliative care
context [22]. The same type of intervention among pa-
tients with gastric cancer (n = 72 + 72) implemented by a
nurse specialist had a positive effect on nutritional in-
take, haemoglobin, total serum and albumin levels, as
well as on chemotherapy compliance rate [23]. Our lit-
erature search on the subject did not find other results
of nurse-led studies, so there is still a lack of nursing-
specific outcomes of nutrition-related interventions. In
general, educational nursing interventions have shown
positive outcomes on the level of knowledge and symp-
tom severity yet the results have been inconsistent on
QoL among patients with cancer [24].
Self-care at home between the chemotherapy cycles
has an important role in the success of overall care. Self-
care involves both the ability to care for oneself and the
activities necessary to achieve, maintain, or promote
one’s optimal health. Through self-care, various out-
comes may be achieved; for example, improved symp-
tom control, coping with the illness, and QoL. In
addition, health services usage and costs may decrease
[25]. In this study, self-care is seen as an ability to man-
age NIS and gain control over one’s health. We use
empowering patient education and teach-back method
to support patients in their self-care.
Empowerment refers to the ability to manage the chal-
lenges of the illness and having a feeling of control over
one’s life. It is perceived as an inner strength of a human
[26, 27]. Empowerment occurs when individuals’ cap-
acity to think critically and make informed decisions is
supported and they make decisions about their own care
[28]. Empowerment is created in dialogue in nurse-
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patient relationship [29] as nurses support patients by
offering knowledge and assist them to find, construct
and use their own resources in self-care. The dimensions
of empowerment can be categorised as experiential (pa-
tients’ earlier experiences), functional (function of one’s
body and mind), ethical (feeling of being valued and
respected), financial (affording support, technical aids),
bio physiological (knowing one’s own body and its
symptoms), social (interaction with other people) or cog-
nitive (knowledge for improving one’s health) [26, 30].
In this study, empowerment is seen as a process where
the nurse supports patients’ empowerment to be more
active in self-care. During this process, patients gain
knowledge to develop skills for NIS-related problem-
solving in daily life [27, 28] in order to reduce the risk of
malnutrition and promote the QoL.
Previous studies examining patients’ expectations to-
wards their care demonstrate the expectation of having
knowledge [31–33] to manage NIS and own health inde-
pendently at home. As nutritional care is seen as part of
fundamental care [34], nurses have a good opportunity
to support patients’ empowerment on self-care of NIS
and prevent the risk of malnutrition during chemother-
apy. With this research protocol, we answer the question
how the empowering educational nursing intervention
using teach-back method will be tested on self-care acti-
vation, knowledge level (primary outcomes), QoL and
risk of malnutrition (secondary outcomes) among pa-
tients with CRC during chemotherapy.
Methods
Aim, design and setting of the study
The aim of this intervention is to improve patients’
empowerment in self-care. The design is a two-arm,
single-centre trial with stratified randomisation (1:1)
with repeated measures (Fig. 1). We hypothesise that
patients with CRC who receive nurse-led empower-
ing education of NIS vs standard education have
higher self-care activation level, better knowledge
level, less risk of malnutrition and less worsening of
QoL at 2 months’ follow-up compared to the control
group (CG).
The study setting is a large university hospital in
Southern Finland, responsible for specialised health
care for about 2.1 million people. In the Cancer
Centre outpatient clinic, about 4500 patients diag-
nosed with CRC (colon, rectum) receive chemother-
apy treatment annually. Up to 40 new patients per
month come for an evaluation of chemotherapy
initiation.
Characteristics of participants
Eligible participants are adult men and women diag-
nosed with CRC, > 18 years and having oral fluoropyri-
midine or combination chemotherapy treatment.
Exclusion criteria are physical, cognitive or psychological
impairment preventing participation and insufficient
comprehension of Finnish language.
Fig. 1 Study design
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Intervention
Standard care
Patients both in CG and intervention group (IG) receive
standard education delivered by a registered nurse (RN)
during the first visit in the outpatient clinic and later on
in the infusion unit. Standard education includes the fol-
lowing verbal information:
– side effects and their self-care; nausea, diarrhoea, ob-
stipation and sores in the mouth, peripheral neur-
opathy symptoms, local venous irritation, heart
symptoms, mucous and skin irritation
– self-monitoring of NIS, fluid intake, medication dose




– importance of varied diet
– oral nutritional supplements
– clinical nutritionist services
Standard education includes the following written
information:
– ‘Nutrition guide for cancer patients’
– ‘Instructions for those receiving anticancer
treatment’
– ‘Information on strong opioids’
– ‘Cancer pain management’
– ‘Anti-nausea medication’
– ‘When you have nausea’
– ‘Management of diarrhoea’
– ‘Management of constipation’
– ‘Oral care instructions for cancer patients’
In addition to a RN, physicians give patients instruc-
tions on medication and related side effects.
Intervention protocol
The intervention was developed during autumn 2018
and spring 2019 by an interdisciplinary expert group
consisting of two RN experienced in oncology, a clinical
nutritionist, an oncologist, and the researcher (LT). We
held four shared meetings and additional discussions be-
tween each member and the researcher. According to
the protocol, patients in IG will receive knowledge of
healthy diet and malnutrition. In addition, they will re-
ceive tailored knowledge of NIS. The tailoring is based
on the side effect self-monitoring diary and patient acti-
vation level assessment according to the Patient Activa-
tion Measure (PAM) [35]. In addition, patients receive
knowledge of the prevention of NIS and self-care strat-
egies based on organisation guidelines. The teach-back
method is used to verify participants’ understanding of
the received knowledge, to tailor education, to uncover
health beliefs, and to activate patients in dialogue [36].
Participants have to be able to teach back the main parts
of the knowledge related to malnutrition as well as the
reasons, prevalence, and self-care of the NIS they are
suffering from. The teach-back method has shown a
positive effect in self-care by improving outcomes in
disease-specific knowledge, adherence and self-efficacy
among people with chronic disease. It has also reduced
hospital readmission rates [37].
Empowerment is supported by offering additional
knowledge according to patients’ expectations. In
addition, the research nurse uses active listening and
strengthening self-care strategies that have been success-
ful. The progression of the discourse is based on pa-
tients’ expectations and active involvement: the nurse
provides the patient with expert knowledge and main-
tains an empathic connection to the patient throughout
the session [38].
The content of the educational intervention is as
follows:
– Illustrating the purpose of the session.
– Exploring patients’ current knowledge of healthy
diet and malnutrition, offering additional knowledge
using teach-back.
– Bringing forward individual NIS and their intensity
on a numerical rating scale (NRS) ≥3, and patients’
knowledge expectations, offering additional
knowledge using teach-back.
– Bringing forward performed self-care strategies and
offering additional knowledge using teach-back.
– Bringing forward individual NIS and their intensity
(NRS < 3), offering additional knowledge.
– Making a brief summary.
Due to the COVID-19 pandemic, the intervention was
scheduled for the second chemotherapy course. The
intervention will not entail any extra costs for patients.
In case the intervention cannot be conducted face-to-
face, it is possible to make it available online, e.g. as a
video call.
Intervention nurse
The eligibility criteria for the research nurse comprise
being a registered nurse and experienced in oncology
nursing. The research nurse is trained to deliver the
intervention by the researcher during three-hour face-
to-face sessions held three times. The research nurse an-
swers open-ended questions related to the content and
method of education before the intervention com-
mences. The intervention is delivered systematically
according to the prescheduled protocol. After each
session, the research nurse documents the length and
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content of the intervention. The researcher and re-
search nurse will meet once a week to check that the
protocol is adhered to.
Outcome measures
Primary outcomes are activation in self-care and know-
ledge level. Secondary outcomes are risk of malnutrition
and QoL. The schedule of enrolment, interventions, and
assessments [39] is presented in Fig. 2.
Self-care activation
Self-care activation is measured, as achieving self-
management is one of the most frequent consequences
associated with patient empowerment [29]. In addition,
there is evidence that patient activation is associated
with health-related outcomes. It has been found that ac-
tive people are more likely to have received preventive
care, less likely to smoke or have a high BMI, and have
better clinical indicators (systolic blood pressure, LDL).
In addition, they are less likely to be hospitalised or use
emergency services [40]. Self-care activation is measured
using the Patient Activation Measure (PAM) instrument
[41], which measures patient activation, a concept re-
lated to empowerment. The instrument covers the ele-
ments used to define empowerment (patients’ capacities,
knowledge, behaviours and support by others) [42].
PAM measures individuals’ knowledge, skills and confi-
dence to manage their own health. The questionnaire
consists of 15 items on a 5-point Likert scale. Individuals
fall into one of the following levels of activation along a
0–100-point scale: 1) Being overwhelmed and unpre-
pared to play an active role in own health, 2) lacking
knowledge and confidence for self-care, 3) taking ac-
tion but lacking confidence and skill to support be-
haviours, 4) adopting health supporting behaviours,
but may have difficulties to maintain them in stres-
sing situations. The measure has proved to be highly
valid and reliable with good psychometric properties,
indicating its use in tailoring interventions and asses-
sing changes. In this study, PAM scores are used to
support patient activation individually. Creating situa-
tions where patients can experience success in taking
control of their health is an essential part of effective
self-care support [41, 43, 44].
Fig. 2 Schedule of enrolment, interventions, and assessments
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Knowledge level
Knowledge is seen as essential for empowerment [29].
Knowledge tests have been used to measure the out-
comes in educational interventions, to evaluate their ef-
fect or to monitor the learning progress during
education [45]. Positive outcomes have been reported on
disease-specific knowledge, adherence to medication and
diet as well as on self-efficacy among people with
chronic disease. A positive but inconsistent effect has
also been reported in self-care and hospital readmission
rates [37]. For this study, a knowledge test based on lit-
erature was developed in the research group consisting
of a clinical nutritionist, a physician, nurses experienced
on oncology and the researcher. A clinical nutritionist
and two patient experts validated the test. The responses
required (15 items) are either yes or no. Each correct an-
swer gives one point and total score is the sum of cor-
rect answers. The knowledge test covers the following
topics:
1. Malnutrition; definition and prevalence in patients
with CRC (2 items)
2. Impact of malnutrition on treatment, morbidity and
mortality (2 items)
3. Chemotherapy-induced side effects that may reduce
nutritional status; reasons, manifestation and self-
care (11 items)
Quality of life
QoL is measured as the risk of malnutrition is strongly
associated with QoL in cancer patients initiating adju-
vant chemotherapy [46]. Improved QoL is seen as a
long-term consequence of patient empowerment [29].
QoL is assessed using the Functional Assessment of
Cancer Therapy Scale – Colorectal (FACT-C) [47],
which is a reliable and valid measure and sensitive to
changes in functional status [48]. The questionnaire con-
sists of 36 items on a 5-point Likert scale in four areas
of wellbeing: physical (0–28 points), social (0–28 points),
emotional (0–24 points), functional (0–28 points) and
CRC subscale (0–28 points). Total sum is 0–136 points.
Higher score means better QoL. Points are assigned for
low level (0–34 points), satisfactory (34–68 points), aver-
age (68–102 points) and high level (102–136 points).
FACT-C has been shown to have good overall validity
and reliability, to be short, have flexible scoring, respon-
siveness to change in performance status, to be signifi-
cantly correlated with other assessments of mood and
show positive results in hypothesis testing [49, 50].
Risk of malnutrition
The risk of malnutrition is assessed as the educational
intervention is presumed to prevent malnutrition or re-
duce the risk of malnutrition. In diagnostic assessment
of malnutrition, the following criteria are recommended:
non-volitional weight loss, low body mass index (BMI),
reduced muscle mass, reduced food intake or assimila-
tion and disease burden/inflammation [51]. To identify
the patients at risk, we use the validated Nutritional Risk
Screening 2002 tool (NRS2002) [52], which was devel-
oped to detect the presence of malnutrition and to pre-
dict whether malnutrition is likely to worsen due to
patients’ illness [53]. Patients are assessed based on BMI,
recent weight loss percentage and change in food intake
(0–3 points), age (0–1 points) and severity of disease (0–
3 points). The total sum is seven points. Patients with a
total score of ≥3 are classified as nutritionally at risk.
Side effects
Side effect self-monitoring is used to assess the intensity
of the side effects as well as to reinforce the intervention
effect by reflecting on the self-care activities. After the
first chemotherapy treatment, nurses give the self-
monitoring diary to patients in both IG and CG, to be
returned to the researcher after the fourth (or the last)
chemotherapy cycle. Patients in IG document the side
effects and their intensity as they appear (NRS 0–10; 0 =
not at all, 10 = the worst possible) before and after the
performed self-care activities. In addition, patients docu-
ment their individual expectations for additional know-
ledge, and this information is used during the
educational intervention. Patients in CG only self-
monitor and document the intensity of each side effect
as it appears (NRS 0–10; 0 = not at all, 10 = the worst
possible).
Clinical data
Clinical data is gathered from electronic patients’ re-
cords. We are interested to find out whether the educa-
tional intervention is related to better adherence to
treatment schedule. Therefore, data of patient-induced
treatment changes, cancellations, transferring and inter-
ruptions are documented from baseline to 8 weeks. It
has been indicated that worse nutritional status is re-
lated to greater morbidity [17]. Therefore, we collect
data of patients’ emergency room visits and hospitalisa-
tion from baseline to 8 weeks.
The sample size was calculated to detect a 7-point
mean difference in the PAM scale between groups as-
suming standard deviation of 11 points for both groups
with 80% power and significance level of 0.05. This leads
to required sample size of 40 participants per group.
The meaningful difference between the average score of
individuals who engage in healthy behaviours and those
who do not is considered 4 points on the PAM scale
[44]. To reach the target sample size (40 + 40), the re-
searcher recruits participants by sending questionnaires
with a research info and contacting them by phone the
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day before they visit the outpatient clinic. The researcher
also meets the eligible participants to provide verbal in-
formation of the trial and answer questions. The strat-
egies to improve patients’ adherence to the intervention
protocol comprise the use of a self-monitoring diary and
positive feedback from the research nurse. For individual
participants, the intervention will be discontinued in the
case of worsening condition, treatment change, or at
their own request.
Assignment of interventions
The researcher (LT) enrols the participants, and those
willing to participate are randomly assigned to CG and IG
using stratified randomisation according to stage of dis-
ease and existence of stoma. An allocation sequence using
blockrand package [54] in R version 3.6.1 [55] was used.
For each block, the block size was randomly chosen from
a set of 2, 4 and 6. Allocation ratio of 1:1 was used. The
statistician generated an unpredictable allocation sequence
using sequentially numbered, opaque, sealed envelopes.
The envelopes, numbered in advance, are opened sequen-
tially after the participant’s name is written on the appro-
priate envelope [56]. The researcher (LT) allocates
participants to the intervention with equal probability as a
simple random sample is drawn from each group. Thus,
the person enrolling participants does not know in ad-
vance which treatment the next person will get [39]. Pa-
tients' blinding is not possible as the RN informs the
patients in IG of the one-hour educational session. The re-
search nurse cannot be blinded because she provides the
intervention. The data analyst is blinded as data are anon-
ymised by using codes (001, 002 etc.).
Data collection
Baseline measurement (M0) is conducted before pa-
tients’ first contact in the outpatient clinic. Follow-up
measurement (M1) is conducted 8 weeks after the
intervention. The duration of a chemotherapy treat-
ment varies from 3 to 6 months. The occurrence of
chemotherapy side effects is individual and they are
principally temporal being most severe in 3–7 days
after each cycle. During the two-month follow-up
period, patients have received four cycles of treat-
ment, which is considered sufficient to assess the ef-
fects of the intervention. The researcher sends
research information and baseline questionnaires
(demographic data, PAM, knowledge test, FACT-C,
NRS2002) to the patients with a return envelope
enclosed. She contacts potential participants by phone
before their first treatment to inform about the study
and asks for their verbal consent. Patients return the
questionnaires within a week before the first appoint-
ment in the outpatient clinic. In connection with this
appointment, the researcher contacts the participants
for verbal research info and written informed consent.
Recruitment continues until the sample size is
reached (40 + 40). The enrolment period will last 4–5
months based on calculated sample size and the as-
sumption of 10 new CRC patients a week and that
approximately 10% of the patients will refuse to par-
ticipate. Outcome data is not collected on participants
who suspend on their own initiative or deviate from
intervention protocols. The researcher manages data
confidentially by entering and storing data on a
password-protected computer. Original study ques-
tionnaires are kept at the participating site. The re-
searcher codes data for ease of data storage, review,
tabulation, and analysis. Files in electronic and paper
form will be discarded after the publication of the re-
search results (2022). In the information letter, pa-
tients are instructed to report spontaneously any
unintended effects to an outpatient clinic nurse.
Nurses report these events to the physician and first
author, who make the final decision to discontinue
the study, if necessary. A formal data monitoring
committee will not be set up due to the short dur-
ation of the study and the harms are known to be
minimal.
Data analysis
Statistical methods are used for analysing primary and
secondary outcomes between the two groups and related
factors. The main analysis is to compare the change
from M0 to M1 in primary outcomes (patient activation
and knowledge level) and secondary outcomes (QoL and
risk of malnutrition) between IG and CG. Categorical
variables will be described using frequencies and per-
centages. Continuous variables will be expressed as
means with standard deviations for normally distributed
variables and medians with interquartile ranges for non-
normally distributed variables. The differences in
changes between groups in continuous outcomes will be
compared with two-sample t-test or Mann-Whitney U-
test and the changes within groups with paired t-test or
Wilcoxon signed rank test, as suitable. Logistic regres-
sion using generalised estimating equation (GEE) will be
used to test the differences between and within groups
at risk of malnutrition (classified as 0–2 and 3–7). Re-
sults will be presented using estimates of group differ-
ences with 95% confidence intervals. The effect of
missing data on the results will be examined using sensi-
tivity analysis. An intent-to-treat analysis will be applied
and two-sided statistical tests with significance level of
0.05 will be used in the statistical analyses. Methods for
any additional analyses are determined by the data.
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Access to data
The searcher has access to the final trial dataset. A con-
tractual agreement is made with the statistician to han-
dle the data confidentially according to the research
protocol.
Discussion
We developed a study protocol to test the effectiveness
of an empowering educational nursing intervention
using the teach-back method on the self-care activation
and knowledge level (primary outcomes), QoL and risk
of malnutrition (secondary outcomes) among patients
with CRC during chemotherapy. This study is currently
in the recruitment phase (first enrolment 21.10.2019).
Today, various Internet-based interventions are offered
for patients with cancer. A vast amount of information
is available from different sources. Patients with colorec-
tal cancer are usually older people and the Internet is
not available for all. Individualised interventions have
proved effective on patients’ energy and protein intake,
weight, QoL, morbidity, mortality and the risk of adverse
clinical outcomes. Previous studies have concentrated
merely on clinical outcomes and QoL. Therefore, we are
interested to test the effectiveness of face-to-face indivi-
dualised education on patients’ self-care activation and
knowledge level. The intervention has potential to im-
prove nutritional outcomes for patients affected with
CRC. If the empowering patient education with teach-
back method proves to be effective, it will be imple-
mented as a part of RNs’ daily work. Further research
will provide valuable information of costs and benefits
when implementing this educational programme. At the
protocol phase, the cost of training the intervention
nurse and staff (20 h) and the salary cost of the research
nurse (8 months) is approximately € 15,000.
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